Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Breast 1

Conditions

Breast Neoplasms 22Unspecified Adult Solid Tumor, Protocol Specific 3Prostatic Neoplasms 3Colonic Neoplasms 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Rectal Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urogenital Neoplasms 1Stomach Neoplasms 1Sarcoma 1Prostatic Diseases 1Pancreatic Neoplasms 1Pain 1Non-squamous Non-small Cell Lung Cancer 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Genital Neoplasms, Male 1Genital Diseases, Male 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma 1Breast Cancer Organoids 1

Interventions

Carboplatin 44Paclitaxel 41Cyclophosphamide 21Topotecan 19Cisplatin 18Peripheral Blood Stem Cell Transplantation 15Filgrastim 15Docetaxel 15Gemcitabine 13Bevacizumab 13liposomal doxorubicin 11Hyperthermic Intraperitoneal Chemotherapy 11sargramostim 9Therapeutics 8Immunohistochemistry 8Psychiatric Rehabilitation 7Drug Therapy 7Amifostine 7pembrolizumab 6olaparib 6Taxes 6Surveys and Questionnaires 6Melphalan 6Flow Cytometry 6Early Intervention, Educational 6Chemotherapy, Adjuvant 6niraparib 5denileukin diftitox 5Surgical Procedures, Operative 5Immunoenzyme Techniques 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Ovarian Epithelial × ixabepilone × Clear all
NCT03093155 2024-05-14

Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab

Yale University

Phase 2 Completed
78 enrolled 18 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00005807 2018-10-09

BMS-247550

Albert Einstein College of Medicine

Phase 1 Completed
40 enrolled
BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

NCT00030706 2018-09-28

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Montefiore Medical Center

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡